Skip to main content

Navigation group

Type at least 3 characters
2,924 articles

Articles

Study Protocol

Published on 19 Jul 2022

A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study

in Molecular and Cellular Oncology

  • Magali Rebucci-Peixoto
  • Angélique Vienot
  • Olivier Adotevi
  • Marion Jacquin
  • Francois Ghiringhelli
  • Christelle de la Fouchardière
  • Benoit You
  • Tristan Maurina
  • Elsa Kalbacher
  • Fernando Bazan
A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study
Frontiers in Oncology
doi 10.3389/fonc.2022.957580
  • 5,295 views
  • 14 citations